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Abstract
Aurora-A regulates the recruitment of TACC3 to the mitotic
spindle through a phospho-dependent interaction with clathrin
heavy chain (CHC). Here, we describe the structural basis of
these interactions, mediated by three motifs in a disordered
region of TACC3. A hydrophobic docking motif binds to a previ-
ously uncharacterized pocket on Aurora-A that is blocked in
most kinases. Abrogation of the docking motif causes a delay in
late mitosis, consistent with the cellular distribution of Aurora-A
complexes. Phosphorylation of Ser558 engages a conformational
switch in a second motif from a disordered state, needed to
bind the kinase active site, into a helical conformation. The helix
extends into a third, adjacent motif that is recognized by a heli-
cal-repeat region of CHC, not a recognized phospho-reader
domain. This potentially widespread mechanism of phospho-
recognition provides greater flexibility to tune the molecular
details of the interaction than canonical recognition motifs that
are dominated by phosphate binding.
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Introduction
Aurora-A is a Ser/Thr protein kinase that regulates mitotic entry and
mitotic spindle assembly (Nikonova et al, 2013) through phosphory-
lation of many substrates. These include TACC3, a member of the
transforming acidic coiled-coil family of proteins, which have
conserved functions in microtubule dynamics (Peset & Vernos,
2008). The requirement of Aurora-A phosphorylation for localization
of TACC3 to spindle microtubules is conserved in the Drosophila
ortholog D-TACC, and the Xenopus ortholog maskin (Giet et al,
2002; Kinoshita et al, 2005; Peset et al, 2005). Phosphorylation of
human TACC3 on S558 drives an interaction with the ankle region of
CHC to form a complex that binds the microtubule lattice through
the coiled-coil region of TACC3 and the b-propeller domain of CHC
(Fig 1A, right; Fu et al, 2010; Hubner et al, 2010; Lin et al, 2010;
Hood et al, 2013). This complex, together with ch-TOG, localizes
along the spindle forming bridges between parallel microtubules of
the kinetochore fibres (K-fibres). These bridges help to stabilize K-
fibres and contribute to spindle robustness while unphosphorylated
TACC3 is targeted to the plus-ends of microtubules by ch-TOG inde-
pendently of Aurora-A and CHC (Burgess et al, 2015; Gutierrez-
Caballero et al, 2015). CHC lacks a canonical phospho-reader
domain and it is unclear how it recognizes phosphorylated TACC3.
The activity of Aurora-A is controlled through phosphorylation
of its activation loop on T288 (Bayliss et al, 2003; Eyers et al,
2003). Like many of its other binding partners, such as TPX2, I-2,
HEF1, and N-Myc, TACC3 is an Aurora-A activator (Nikonova et al,
2013; Richards et al, 2016). However, only in the case of TPX2 has
the mechanism of activation, and how this synergizes with phos-
phorylation of T288, been resolved (Bayliss et al, 2003; Eyers et al,
2003; Dodson & Bayliss, 2012). Amino acids (aa) 1–43 of TPX2 stim-
ulate Aurora-A activity, whether T288 is phosphorylated or not, and
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TPX2-binding and T288 phosphorylation together stabilize the aC-
helix and activation loop in a fully ordered conformation (Fig 1A,
left) similar to that observed in active Ser/Thr kinases, such as PKA
(Bayliss et al, 2003; Goldsmith et al, 2007; Dodson & Bayliss, 2012;
Zorba et al, 2014; Cyphers et al, 2017). This mechanism is antago-
nized by a single domain antibody that traps Aurora-A into an inac-
tive conformation (Burgess et al, 2016). The only other structure of
a physiological Aurora-A protein complex is with a fragment of N-
Myc, which binds primarily to the activation loop and only partially
overlaps the TPX2 binding site (Richards et al, 2016). TACC3 binds
Aurora-A through a region 30aa N-terminal to the S558 phosphory-
lation site, centred on a critical phenylalanine residue, F525
(Burgess et al, 2015). The location of the TACC3 binding site on
Aurora-A is unknown, but is distinct from that of TPX2 because a 3-
way complex can be formed in vitro (Burgess et al, 2015). It is not
known whether Aurora-A/TPX2 and Aurora-A/TACC3 complexes
co-localize on the mitotic spindle, or how their localizations change
as mitosis develops.
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Figure 1. Three interaction sites in the crystal structure of Aurora-A/TACC3.
A Schematic illustration showing the domain structures and interacting regions of Aurora-A, TPX2, CHC and TACC3. TPX2 1–43 stabilizes the active conformation of
Aurora-A through interactions with the aC-helix and the phosphate-bearing activation loop (left). TACC3 F525 is crucial for the interaction with Aurora-A (i).
Phosphorylation of TACC3 S558 by Aurora-A (ii) is required for the subsequent interaction with the CHC ankle region (iii).
B View of the Aurora-A/TACC3 structure centred on the TACC3 molecule (orange surface), which interacts with three molecules of Aurora-A (blue, light blue, teal
cartoon).
C View of the Aurora-A/TACC3 structure centred on one Aurora-A molecule (teal cartoon), which interacts with three molecules of TACC3 (orange, red, brown).
D Diagram showing which TACC3 residues interact with Aurora-A at each of the three sites (teal, blue and light blue boxes), with key interactions marked as “+” and
secondary structure of TACC3 indicated. Backbone chemical shift mapping is of inactive Aurora-A upon addition of TACC3N-ACID (solid line; Burgess et al, 2015).
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Aurora-A regulation of binding between TACC3 and CHC is criti-
cal for the proper and timely assembly of the mitotic spindle. We
have mapped the interacting regions that mediate the processes by
which TACC3 is recognized by Aurora-A, phosphorylated, and then
handed over to CHC, but detailed structural insights are required to
determine how TACC3 activates Aurora-A without binding to the
same regulatory site as TPX2 and how phosphorylation of TACC3
directs its interaction with CHC. Here, we find that the region
around F525 of TACC3 is a docking motif that binds to a site on the
surface of Aurora-A that is blocked in kinases such as PKA. Disrup-
tion of the docking motif by point mutation impairs localization of
TACC3 on the mitotic spindle and delays the completion of mitosis.
In unphosphorylated TACC3, the region between the docking site
and S558 contains a nascent a-helix. Phosphorylation at S558 stabi-
lizes and extends this a-helix, displaying a pattern of hydrophobic
residues that is recognized by a complementary surface in the ankle
region of CHC.
Our study extends the current paradigm that the role of phospho-
rylation in signalling pathways is to promote complex formation
via phospho-specific reader modules because a phosphorylation-
induced helix could be read by a wide range of proteins, most obvi-
ously those comprising helical repeats like CHC. Furthermore, this
mechanism of phosopho-recognition, in which the sequence motif
that governs the stabilization of the helix is distinct from that used
to form the interface with the reader, provides greater flexibility to
tune the molecular details of the interaction than canonical recogni-
tion motifs which are dominated by phosphate binding.
Results
Crystal structure of the Aurora-AKD/TACC3N-ACID complex
Our previous work, summarized in Fig 1A, mapped the regions that
interact in the complex between the Aurora-A kinase domain and the
N-terminal fragment of the Aurora-A and CHC interaction domain
(ACID) of TACC3 corresponding to aa519–563 (TACC3N-ACID;
Fig EV1A; Burgess et al, 2015).
Crystals of TACC3N-ACID bound to an Aurora-A 122–403 C290A,
C393A, D274N mutant (Aurora-AM3KD) diffracted to 2.0 A˚ resolution
(Table 1). The structure was solved by molecular replacement (MR)
using an existing Aurora-A structure (PDB 4CEG; Burgess & Bayliss,
2015). Unambiguous electron density for TACC3N-ACID was observed
(Fig EV1B), and one complex was located in the asymmetric unit.
Residues 126–280 and 290–392 of Aurora-AM3KD were included in
the final model, with the part of the activation loop being disordered
consistent with its unphosphorylated state (Cheetham et al, 2002;
Burgess et al, 2016). TACC3N-ACID mostly adopts an extended
conformation but with two short regions of secondary structure: a
310-helix formed by 528–530, and an a-helix by 546–555 (aTR). Due
to crystal packing, each molecule of TACC3N-ACID contacts three
molecules of Aurora-AM3KD (Fig 1B). These contacts cover the entire
length of TACC3N-ACID, which allowed it to be fully resolved, and
involved three distinct sites on the surface of Aurora-AM3KD (la-
belled as sites 1–3; Fig 1C and D). However, this is unlikely to repre-
sent the physiological arrangement of the complex and it would not
be possible for a single TACC3N-ACID molecule to occupy all three
sites simultaneously (Fig 1D).
Of the three sites, only the contact at site 1 is consistent with
our previous data: an F525A mutation increased the Kd of the
interaction from 5.7 to >150 lM and chemical shift changes in
1H-15N HSQC spectra of TACC3N-ACID upon addition of Aurora-A
were restricted to aa521–535 (solid black line, Fig 1D; Burgess
et al, 2015). Interestingly, site 2 overlaps with the binding site for
TPX2, but there is no conserved secondary structure between
TPX2 and TACC3 and the chains run in opposite directions over
the surface of Aurora-A. To further validate in solution the confor-
mation and interactions of TACC3 519–540 observed in the crystal
structure, we extended our previous nuclear magnetic resonance
(NMR) studies by fully assigning C and H atom resonances in the
519–540 region both free in solution and bound to Aurora-A
(Fig EV1C and D). The greatest observed changes in chemical shift
were observed for H atoms in side chains that contact Aurora-A
site 1 in the crystal structure such as F525 (Hd and He) and P528
(Hd; Fig EV1C) and the side chain of R526 (Hd), which makes only
modest contact with Aurora-A but folds back against the 310 helix
of TACC3, close to the acidic side chain of E530 (Fig 2A). Also,
upon binding, the chemical shifts of the L532 Hd atoms are clearly
shifted away from their positions in the free form, one upfield and
one downfield, by packing against Y148 of Aurora-A (Figs 2A and
B, and EV1D). The changes in chemical shifts are therefore consis-
tent with conformational changes in TACC3 and interactions with
Aurora-A at site 1.
Mutations at site 1 disrupt the interaction and reduce
Aurora-A activation
The interaction at site 1 involves residues 523–535 of TACC3N-ACID
binding to the surface of the b-sheet in the Aurora-A N-lobe (Fig 2A
and B) contacting b-strands b1–b3 and b5 and adopting an extended
conformation, with the exception of a short 310-helix at aa527–532.
The total surface area buried in this interface is ~950 A˚2, and the
key contributions are made by TACC3 residues F525, L532, P528,
and Aurora-A residues I135 and R151 (Fig 2B). I135 of Aurora-A is
sandwiched between the side chains of TACC3 F525 and L532. The
F525 side chain is inserted into a pocket formed by the side chains
of R151, I158, L149, E134, and main chains of G136 and A150, of
Aurora-A. The interface also involves an intermolecular salt bridge
between E523 of TACC3 and R137 of Aurora-A and a H-bond
between the main chain oxygen of TACC3 R526 and the main chain
amine of Aurora-A I135.
The contributions of the site 1 residues to the interaction were
quantified using fluorescence polarization spectroscopy (FP) with a
set of fluorescein (FAM)-labelled peptides. The Kd of FAM-WT TACC3
519–570 binding to Aurora-A was measured as 3.0  0.2 lM
(Fig EV2A), which is in good agreement with the Kd measured by
microscale thermophoresis (MST) and NMR for TACC3N-ACID binding
to Aurora-A (6–8 lM; Burgess et al, 2015). The Kd of the WT TACC3
522–536 peptide binding to Aurora-A was 20  1 lM by FP suggest-
ing that the docking interaction at site 1 is the major contributor to the
overall interaction while the region of TACC3 in the vicinity of S558
makes a minor contribution, consistent with an enzyme–substrate
interaction (Fig 2C and D; Burgess et al, 2015). The affinity of a
TACC3 522–536 peptide incorporating the F525A mutation was extre-
mely weak (2.3  0.4 mM), consistent with the major contribution of
F525 to the interface (155 A˚2 buried surface area). L532 contributes
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the second greatest buried surface area of TACC3 residues at site 1
(97 A˚2), and a L532A mutant peptide had 10-fold reduced affinity
(Kd = 251  14 lM). In contrast, an R526A mutant peptide bound
Aurora-A with an only modestly reduced affinity (49  2 lM), consis-
tent with its contribution to the interaction being through the main
chain (Fig EV2B). Mutations within the pocket on Aurora-A which
accommodates the F525 side chain (E134A, R137A, L149A, R151A
and I158A mutations) all reduced the affinity for the WT TACC3 522–
536 peptide. The strongest effect was observed for R151A, which
reduced affinity by 40-fold (Kd = 771  61 lM; Fig 2D).
We have previously shown that TACC3 stimulates the activity of
Aurora-A, and we therefore investigated the contribution of the inter-
face to this process (Burgess et al, 2015). In a 32P-ATP kinase assay,
WT TACC3N-ACID stimulated Aurora-A activity by eightfold, while
F525A or L532A mutants stimulated activity by only twofold–three-
fold (Fig EV2C). The Aurora-A R151A mutation that disrupted the
binding interaction to the greatest extent resulted in reduced stimula-
tion by TACC3. These key interaction residues are conserved between
TACC3 and Aurora-A orthologs (Fig EV2D). To characterize how
TACC3 activates Aurora-A, a kinase assay was performed using
unphosphorylated Aurora-A kinase domain and Aurora-A D274N (ki-
nase-dead) as a substrate (Fig 2E). WT TACC3N-ACID stimulated both
Aurora-A autophosphorylation and substrate phosphorylation on
T288. These phosphorylation events were reduced in the presence of
TACC3N-ACID F525A indicating TACC3 is an allosteric activator of the
kinase and enhances substrate phosphorylation.
Table 1. Data collection and refinement statistics.
Aurora-AM3KD/TACC3
519–563 (PDB 5ODT)
CHC-(TGS)4TACC3
549–570pS558 (PDB 5ODS)
Data collection
Space group I2 3 P 1 21 1
Cell dimensions
a, b, c (Å) 137.04, 137.04, 137.04 115.52, 120.04, 123.13
a, b, c (°) 90.00, 90.00, 90.00 90.00, 95.72, 90.00
Resolution range (Å) 68.52–2.02 (2.07–2.02)a 61.26–3.09 (3.14–3.09)a
Rmerge (%) 8.7 (193) 8.4 (123)
I/rI 25.9 (1.9) 10.3 (1.2)
Completeness (%) 100 (100) 98.7 (99.6)
Redundancy 20.2 (20.5) 3.3 (3.4)
Refinement
Resolution (Å) 68.52–2.02 61.26–3.09
No. reflections 28,159 60,649
Rwork/Rfree 17.78/21.11 22.08/26.9
No. atoms
Protein 2,372 18,224
Water 140 0
Hetero 65 0
Mean B-factors
Protein 43.78 124.5
Hetero 57.19 –
Water 49.84 –
Wilson B-factor 41.27 99.33
r.m.s. deviations
Bond lengths (Å) 0.008 0.006
Bond angles (°) 1.047 1.204
MolProbity analysis
All-atom clash-score 3.35 5.96
Ramachandran allowed (%) 3.05 5.06
Ramachandran outliers (%) 0 0
Ramachandran favoured (%) 96.95 94.94
MolProbity score 1.31 2.73
aValues in parentheses are for highest resolution shell.
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Figure 2. TACC3 523–534 forms a docking interaction on the N-lobe of Aurora-A.
A Magnified view of the site 1 interaction.
B Schematic showing the key features of the TACC3/Aurora-A interface.
C FP assays of binding between site 1 of TACC3 and Aurora-A. The sequence of TACC3 present in the complex crystal structure is shown (top) with the residues of the
site 1 FP peptide coloured orange and mutated residues identified by coloured circles corresponding to the curves shown in the FP assay (below). Data represent
mean of three experiments  SD. The binding affinity between WT Aurora-A and FAM-TACC3 522–536 was 20  1 lM. L532A and F525A mutations resulted in
reductions in affinity to 251  14 lM and 2.3  0.4 mM, respectively.
D FP assays between FAM-labelled TACC3 site 1 peptide and Aurora-A mutants (as labelled). Data represent mean of three experiments  SD. The binding affinity
between WT Aurora-A and FAM-TACC3 522–536 was 20  1 lM. The affinities between FAM-TACC3 522–536 and the Aurora-A point mutants were all reduced
compared to the WT. The E134A mutant had an affinity of 98  5 lM; R137A, 149  7 lM; L149A, 79  4 lM; R151A, 771  61 lM; and I158A 163  8 lM for
TACC3.
E Kinase assay to monitor autophosphorylation of unphosphorylated Aurora-A KD and substrate phosphorylation of kinase-dead Aurora-A D274N alone and in the
presence of TACC3. Reactions were analysed by SDS–PAGE (above) and Western blotting with an aphospho-T288 Aurora-A antibody (below).
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Based upon NMR and biochemical data, we conclude that the
interaction of TACC3 in solution is that observed at site 1 in the
crystal structure and that this site contributes to the activation of
Aurora-A by TACC3.
A model for allosteric activation of Aurora-A by TACC3
In the complex with TACC3N-ACID, Aurora-AM3KD is in an inactive
conformation in which the aC-helix is distorted and K162 and
E181 are separated and unable to form a salt bridge (Fig 3A).
Furthermore, the path of the activation loop diverges from that of
an active kinase and is disordered between aa281 and aa289. This
is consistent with the inactive biochemical state of the Aurora-
AM3KD in the complex, which was not phosphorylated on T288. In
contrast, the crystal structure of T288-phosphorylated Aurora-AKD
in complex with TPX21-43 reveals an active conformation with a
salt bridge between L162 and E181 and an ordered activation
loop, similar to that of the canonical kinase PKA (Fig 3B and C;
Knighton et al, 1991; Bayliss et al, 2003). The DFG-motif of
Aurora-AM3KD in complex with TACC3N-ACID adopts a twisted
conformation that directs the activation loop up towards the N-
lobe. However, the side chain of Phe275 is located in the expected
position for an active, DFG-in conformation, as in the Aurora-A/
TPX2 structure (Fig 3D). This contrasts with previous structures
of inactive Aurora-A with a distorted aC-helix, in which the side
chain of Phe275 occupies a pocket in the N-lobe (DFG-up), form-
ing interactions that may stabilize the distorted conformation of
the aC-helix (Fig 3E). Although Aurora-A can adopt an active
conformation when unphosphorylated (e.g. PDB code 1MQ4), this
reflects the dynamic nature of the kinase, which can be trapped
in inactive or active states depending on crystallization condi-
tions. We are therefore cautious about drawing conclusions
regarding the mechanism of activation based on the conforma-
tion of the kinase that might be influenced by crystal packing
interactions (such as site 2 and site 3). Nevertheless, the confor-
mation of Aurora-A in the presence of TACC3 appears to be an
intermediate step towards activation, and we speculate that this
is how TACC3 allosterically activates Aurora-A. Notably, the
opening in which the activation loop sits is widened by move-
ment of the Gly-rich loop, formed from the b1 and b2 strands
that interact with TACC3 (Fig 3D). This could lower the ener-
getic barrier to movement of the Phe side chain of Aurora-A,
opening space for the aC-helix to reposition and the Lys-Glu salt
bridge to form as a precursor to autophosphorylation (Fig 3F).
This contrasts with the mechanism by which TPX2 activates
Aurora-A, through direct interactions with the aC-helix (Zorba
et al, 2014; Bayliss et al, 2017).
The TACC3 binding site on Aurora-A is distinct from the TPX2
binding site and has not previously been identified as a site of
protein–protein interactions in this kinase. We therefore examined
the corresponding site in the structures of other kinases
(Fig EV3A–E). The b-sheet which in Aurora-A forms the TACC3
binding site is a conserved structural feature of the kinase N-lobe.
However, the residues that line the binding site for TACC3 are not
conserved: G136 of Aurora-A is replaced by a bulky residue in most
kinases, blocking the pocket that is recognized by F525 of TACC3
(Fig EV3A); many kinases have a “N-lobe cap” sequence that
extends from the N-terminus of the kinase domain and blocks the
“N-cap” pocket that in Aurora-A remains open for recognition by
L532 of TACC3 (Thompson et al, 2009). The N-cap pocket is also
blocked in the AGC family of kinases (Fig 3C; Knighton et al,
1991). TACC3 mimics the interaction of part of the C-terminal
extension of PKA with its core kinase domain (N-cap pocket,
Fig 3A and C). Similarly, TPX2 binding to Aurora-A resembles the
way that other parts of the C-terminal extension (HM pocket, N-cap
pocket) and the N-terminal extension (at the W pocket) interact
with the core kinase domain of PKA. These observations support
the concept of Aurora-A having an incomplete kinase domain that
is complemented by regulatory protein binding partners, when
compared to PKA, which has an intrinsically active kinase domain
because these structural features are encoded into N- and C-term-
inal extensions of the same polypeptide. The same concept applies
to Aurora-B and Aurora-C, which are complemented by the regula-
tory protein INCENP (Sessa et al, 2005). The binding site for
TACC3 on Aurora-A is conserved on Aurora-B and Aurora-C, and
partly overlaps with the INCENP binding site: the pocket on
Aurora-A into which F525 of TACC3 binds is equivalent to that on
Aurora-B/C that fits W801 (Xenopus laevis numbering; Fig EV3F
and G).
Aurora-A in complex with TACC3 has an activation loop confor-
mation that is incompatible with binding of peptide substrates,
which explains why the region of TACC3 around S558 is not bound
close to the active site. This observation raises the question of
whether a single molecule of TACC3 could span both the docking
site 1 and the substrate binding site of Aurora-A. To address this
point, we generated a model of TACC3 bound to active Aurora-A
using FlexPepDock Server (Raveh et al, 2010; London et al, 2011)
and the structure of an active Aurora-A, phosphorylated on Thr288
in complex with TPX2 (Fig 3G). The surface of Aurora-A in the
vicinity of the TACC3 site 1 is virtually identical between active and
inactive states of the kinase, and the TACC3 docking peptide,
aa522–537 adopted a stable conformation, similar to that found in
the crystal structure. We modelled the interaction of the substrate
region of TACC3 (aa553–561) based on the structure of a substrate-
like inhibitor bound to PKA. The TACC3 sequence was readily
accommodated into the equivalent binding pocket of Aurora-A. The
16-residue gap between the docking and substrate motifs is more
than sufficient to span the distance of 24 A˚ between their binding
sites on Aurora-A, as an extended peptide has a spacing of 3.5 A˚ per
residue.
In summary, Aurora-A recognizes TACC3 through a docking
motif to a site of allosteric regulation on the kinase N-lobe. The site
has not been reported as a docking site for substrates, but having
this site blocked in most kinases means that it is a selective site
for binding and regulation of kinases like Aurora-A. We next
investigated the functional consequences in cells of disrupting this
interaction.
Abrogation of the interaction that docks TACC3 to Aurora-A
results in delayed anaphase onset and cytokinesis
Previous studies have revealed that the localization of Aurora-A to
spindle microtubules depends on TPX2 (Bird & Hyman, 2008) and
that the phosphorylation by Aurora-A of TACC3 S558 drives its
interaction with CHC to form a complex that localizes to K-fibres
(Kinoshita et al, 2005; Peset et al, 2005; Fu et al, 2010; Lin et al,
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Figure 3. Structural analysis of the Aurora-A/TACC3 complex.
A Aurora-AM3KD/TACC3N-ACID complex, coloured as in Fig 2A. K162 and E181 (blue spheres) do not form a salt bridge, consistent with an inactive state of the kinase.
B Aurora-AKD/TPX21-43 complex. K162 and E181 (blue spheres) form a salt bridge, consistent with an active state of the kinase (PDB 1OL5).
C Structure of PKA (PDB 1JBP) with the core kinase domain (grey) and N- and C-terminal extensions (magenta). K72 and E91 (blue spheres) form a salt bridge,
consistent with an active state of the kinase.
D Magnified view of the Aurora-AM3KD/TACC3N-ACID complex, centred on the activation loop (red), on which the activation loop from the Aurora-A/TPX21-43 structure
(pink, PDB 1OL5) is superposed.
E Magnified view of the Aurora-AM3/vNAR-D01 complex, centred on the activation loop (brown), which adopts a DFG-up conformation.
F Schematic illustration of the mechanisms through which TPX2 and TACC3 activate Aurora-A.
G Computational model of Aurora-A in its active conformation (based on PDB 1OL5) in complex with docking and substrate regions of TACC3.
Data information: Black arrows in (A–C) indicate hydrophobic contacts that are in structurally conserved locations.
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2010; Hood et al, 2013). All three proteins are localized to spindle
microtubules, but it is not known whether the complexes of Aurora-
A with TPX2 and TACC3 are co-localized. We investigated the speci-
fic localization and timings of the Aurora-A/TACC3 and Aurora-A/
TPX2 interactions using proximity ligation assays (PLA) assays.
HeLa cells were synchronized and imaged at time points through G2
and M phases (Figs 4A and EV4A and B). In G2, there were few
Aurora-A/TACC3 foci across the cytoplasm, but by prophase they
accumulated near the condensed chromatin. During prometaphase,
the foci appeared in prominent clusters that resembled the spindle
poles and by metaphase they had spread along the length of spindle
microtubules in a punctate pattern. Aurora-A/TACC3 complexes
remained associated with spindle poles throughout anaphase and
telophase, although a subset of complexes relocated to the central
spindle/midbody and the overall number of PLA foci was reduced.
Aurora-A/TPX2 and Aurora-A/TACC3 PLA foci showed a similar
localization until late anaphase when Aurora-A/TPX2 relocated
entirely to the central spindle/midbody while Aurora-A/TACC3
complexes were retained at the spindle poles, consistent with the
localization of TPX2 and TACC3. The distribution of Aurora-A does
not perfectly coincide with either of these binding partners
(Fig EV4C–E)—it is more concentrated at spindle poles until cytoki-
nesis, when some relocates to the central spindle, as previously
reported (Reboutier et al, 2013).
Next, we investigated the contribution of site 1 to the localization
of TACC3/Aurora-A complexes in HeLa cells. The F525A point
mutation was introduced into TACC3 in HeLa cells by CRISPR/Cas9-
mediated genome editing. In addition to a cell clone with the desired
F525A mutation (F525A-HeLa), we generated single clones of
control (WT) and TACC3 protein null (ΔTACC-HeLa) cells
(Appendix Fig S1). Sequence analysis of the TACC3 transcripts
present in the F525A-HeLa clone revealed three transcript species in
total. The majority (~80%) was full-length and carried the F525A
point mutation. The smaller group was split between transcripts
encoding a protein product truncated at exon 5, and a product
containing the E519D mutation along with an in-frame deletion of
site 1 (aa520–529). The former is unlikely to be produced in cells,
since no truncated proteins were detected on Western blots probed
with an antibody against an exon 3-encoded portion of TACC3
(Appendix Fig S1C). However, the site 1-deleted form may be
expressed alongside the TACC3-F525A product in the F525A-HeLa
cells, but for simplicity we refer to the TACC3 product in this cell
line as TACC3-F525A. When compared to wild-type TACC3, TACC3-
F525A seemed markedly reduced on mitotic spindles during all
stages of mitosis (Figs 4B and EV4C). Because levels of wild-type
TACC3 and TACC3-F525A were comparable on Western blots, the
F525A mutation impairs spindle targeting and/or retention rather
than protein expression or stability (Appendix Fig S1C). Given the
crucial role of F525 within site 1 (i.e. the Aurora-A docking site) of
TACC3 in vitro, we next assayed its contribution to Aurora-A/
TACC3 complex formation in mitotic cells. In line with the overall
reduction in TACC3 observed on the spindle, PLA-based quan-
tification revealed 50% fewer complexes in both early and late
mitotic F525A-HeLa cells (Fig 4C and D).
We next performed time-lapse imaging of mitosis in WT, F525A-
HeLa and TACC3 null ΔTACC-HeLa cells (Figs 4E and EV4F–H).
Similar to ΔTACC-HeLa, F525A-HeLa progressed more slowly from
nuclear envelope breakdown (NEBD) to anaphase onset than WT
(Fig EV4H). Moreover, the time between anaphase and completion
of chromosome decondensation was also longer in ΔTACC and
F525A-HeLa cells (time in minutes: ΔTACC-HeLa: 48  9, F525A-
HeLa: 49  11, WT: 37  6; Fig 4E). The delay occurred mostly
between telophase and chromosome decondensation (Fig EV4F).
These findings indicate a key role for site 1, and the F525 residue
in particular, during both early and late mitosis (Burgess et al,
2015).
In summary, our results confirm that the site 1 interface
observed in the crystal structure is critical for Aurora-A/TACC3
interaction and also for proper TACC3 localization in mitotic cells.
Crystal structure of a chimeric fusion of CHC with pTACC3
The complex between CHC and TACC3 cross-links microtubules
contributing to the formation of K-fibres and the fidelity of mitosis.
Previous work mapped the CHC-binding region of TACC3 to aa549–
570, which includes the S558 site that must be phosphorylated by
Aurora-A to drive the interaction, but not the Aurora-A docking
motif centred on F525 (Fig 5A; Hood et al, 2013; Burgess et al,
2015). We set out to determine the structural basis of the interaction
between TACC3 and CHC. To help plan our strategy, we first
measured the binding affinity between a CHC propeller-ankle frag-
ment and FAM-labelled TACC3 peptides using FP.
We initially trialled different length CHC fragments and TACC3
peptides phosphorylated on S558 (Figs 5B and EV5A and B). We
then explored the contribution of TACC3 phosphorylation to binding
affinity (Figs 5C and EV5C). Non-phosphorylated TACC3CID (aa549–
570) bound weakly to CHC aa1–574 and, while incorporation of a
phospho-mimic S558E mutation did not increase affinity, phospho-
rylation of S558 enhanced affinity fourfold. Based on these observa-
tions, we generated a fusion protein (ClACC) incorporating CHC
aa1–574 and TACC3CID separated by four Thr-Gly-Ser linkers (TGS4)
with full incorporation of phosphoserine at TACC3 residue 558
(ClACCp) using a genetic encoding system (Appendix Fig S2A–D;
Rogerson et al, 2015). Crystals of ClACCp protein diffracted to
3.09 A˚, and the structure was solved by MR using a model of CHC
1–494 (PDB 1BPO; ter Haar et al, 1998; Table 1).
The ClACCp structure had four chains of CHC aa1–574 and four
chains of TACC3 aa550–567 in the asymmetric unit (ASU). The
TGS4 linker was not resolved (Appendix Fig S2E–J). The residues of
CHC not present in the search model form an additional a-helical
repeat comprising six helices (a11–a16, Fig 5D). Superposition of
the four complexes present in the ASU by alignment of the CHC b-
propeller reveals differences between them in the positions of
helices in the linker and ankle regions (Appendix Fig S2F) due to
the flexibility of these regions. However, when we aligned the ankle
region of the four molecules in the ASU, they were found to super-
impose with Ca RMSD ranging from 0.7 A˚ to 1.2 A˚, and the mode of
interaction of the ankle region with pTACC3 was equivalent in each
(Appendix Fig S2G).
CHC recognizes hydrophobic residues of TACC3 that are displayed
on an a-helix
The core of the interface encompasses TACC3 aa559–565, and the
a10 and a12 helices of CHC (Fig 5D–F). Surprisingly, pSer558 is not
at the core of the interface: the nearest functional group is the
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amine on the side chain of CHC K507, which is ~4 A˚ away but the
weak electron density of this residue suggests mobility, not a stable
interaction. The core of the interface is hydrophobic, and the side
chains of TACC3 residues L559, Y560, F563, and P565 pack against
the side chains of CHC residues L476, L480, R481, L503, Y504, and
K507. The side chain of R481 stacks on the aromatic ring of TACC3
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Figure 4. Defects in spindle localization and late mitotic progression in CRISPR/Cas9-engineered HeLa cells with mutations in TACC3.
A PLA showing Aurora-A/TACC3 (top panel) and Aurora-A/TPX2 (bottom panel) complexes during mitosis in HeLa cells. Cell cycle stages are indicated above cell
images.
B Dot plot indicates volume of TACC3 protein at spindle pole regions of WT and F525A HeLa cells in telophase. Volumes were measured for 90 spindle pole regions
per cell line (45 telophase cells). Representative images are shown in Fig EV4C.
C, D PLA between Aurora-A and TACC3 in WT, DTACC and F525A HeLa cells. Representative metaphase (C), and anaphase and telophase cells (D) are shown in panels on
the left. Box and whisker plots on the right represent the number of PLA dots counted per cell in either metaphase or anaphase/telophase cells, respectively. 30
cells were analysed for each cell cycle stage for each cell line.
E Duration of anaphase to chromosome decondensation, measured by time-lapse microscopy in WT, DTACC and F525A HeLa cells. Number of cells analysed is
indicated on graph (n).
Data information: Cell images include DNA stained with DAPI (blue). Scale bars, 10 lm. In the dot plots (B, E), horizontal lines represent the mean and error bars
correspond to standard deviation. P-values were obtained from Mann–Whitney: ****P < 0.0001. For the box and whisker plots (C, D), the middle horizontal line marks
the median and the box represents the 25th and 75th percentile. The whiskers extend from the minimum to the maximum values. P-values were obtained from Student’s
t-test, unpaired, two-tailed: ****P < 0.0001.
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Y560 and is held in position by the side chain of D455 from a8. In
addition, there is a H-bond between the side chains of TACC3 D564
and CHC S477. Substitutions to alanine of residues L559, Y560, and
F563, from the core of the interface with CHC, in FAM-labelled
pTACC3CID peptides each reduced the affinity for CHC 1–574 in FP
assays by at least fourfold compared to WT (Fig 5G). Thus, these
three hydrophobic side chains each contribute to the interaction,
consistent with the crystal structure. However, mutation of L566/
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Figure 5. Crystal structure of ClACCp.
A Schematic illustration of CHC (grey) and TACC3 (orange) domain structures.
B Summary of the binding data between CHC proteins and TACC3CID peptides. See also panel (G) and Fig EV5A and B.
C FP assays to measure the binding affinity of CHC 1–574 to FAM-labelled TACC3CID phosphorylated (pS558), unphosphorylated (S558) and phosphomimetic (S558E)
forms. See also Fig EV5C.
D Overview of the crystal structure of ClACCp. Note that the linker between CHC aa574 and TACC3 aa550 is disordered.
E Magnified view of the CHC/TACC3 interaction. The side chains of key interacting residues are shown as sticks.
F Schematic illustration of the CHC/TACC3 interface.
G FP binding curves of CHC 1–574 with FAM-phospho-TACC3CID bearing alanine point mutations. Affinities are in parentheses. Data represent mean of three
experiments  SD.
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L567 and L561 to alanine also reduced the binding affinity of the
interaction, while these residues do not make substantial direct
contact with CHC (Fig 5G). We rationalized this with the observa-
tion that the side chains of L566 and L561 pack together to stabilize
the C-terminus of the helix, which is terminated by P565, and thus
may help to position residues such as F563 and P565 on the oppo-
site side of the a-helix that do make substantial contacts with CHC.
However, a wider range of altered CHC-binding properties in the
TACC3 variant peptides should perhaps be expected and so further
functional analysis of the interaction was required to increase confi-
dence in the model of the TACC3/CHC interface.
Next, we examined whether the CHC-TACC3 interaction could be
disrupted by mutations on the surface of CHC, based on analysis of
the crystal structure (Fig 6A). For example, R481 interacts with both
TACC3 Y560 and TACC3 D564 and was mutated to glutamic acid to
disrupt both interactions. We explored the opportunities for disrup-
tion of specific contacts with the side chain of TACC3 F563: L480
nestles against the Cb atom of TACC3 F563 and was mutated to
aspartic acid alone or in combination with a L476D mutation, which
disrupts the hydrophobic surface contacting P565; the double muta-
tion L503A/Y504A removes the pocket into which the phenyl group
of F563 binds; the subtle F492Y mutation introduces an –OH group
that is predicted to clash with the Cb atom of TACC3 F563. The
mutant CHC proteins were expressed and purified as the WT
protein, and binding affinities to the FAM-labelled pTACC3CID were
measured using the FP assay (Fig 6B). The mutation F492Y caused
> 6-fold increase in Kd. The four other mutant CHC proteins were
measured to have Kds for pTACC3
CID of over 300 lM. We conclude
that interaction between CHC and TACC3 in solution is consistent
with that observed in the crystal structure.
We next probed whether the TACC3-CHC interface observed in
the crystal structure was relevant to the function of the interaction
in HeLa cells (Fig 6C and D). We previously showed that the inter-
action between the two proteins is essential for their recruitment to
the mitotic spindle, so here we asked whether the spindle localiza-
tion was impaired in TACC3 or CHC proteins harbouring mutations
in the observed interface.
First, we re-expressed a number of GFP-TACC3 constructs in
HeLa cells depleted of endogenous TACC3 and imaged cells fixed
during metaphase (Fig 6C). In the control cells, GFP alone exhibited
a diffuse, cytoplasmic localization, whereas WT TACC3 was tightly
localized to the spindle. A control mutant, in which residues in the
vicinity of S558 that do not contact CHC were mutated (L561A,
K562A) behaved like WT. In contrast, other mutants (L566A,
L567A; F563A; L559A; Y560A) that disrupt the interaction in vitro
were not localized to the spindle. Furthermore, these mutants were
unable to rescue the localization of endogenous CHC, which has a
clear enrichment to the spindle in WT cells, but a more diffuse local-
ization when TACC3 is depleted.
We then re-expressed the designated GFP-CHC constructs in
HeLa cells depleted of endogenous CHC. In line with previous exper-
iments, WT GFP-CHC, but not GFP alone showed enrichment at the
spindle, although there is a background of cytoplasmic CHC
(Fig 6D). All CHC mutants tested were impaired in spindle localiza-
tion: a control in which the TACC3 interaction site is deleted (Δ457–
507); mutations in the TACC3 binding site (L476D, L480D; R481E;
L503A, Y504A) and mutation of a residue that holds R481 in place
(D455K). However, these data should be interpreted cautiously
because rescue of CHC knockdown with exogenous WT-CHC was
unable to fully restore TACC3 localization to the spindle. Either the
exogenously expressed CHC is impaired in binding TACC3 or the
levels of exogenous CHC are too low, and so we cannot draw defini-
tive conclusions from the rescue experiments with CHC mutants.
Moreover, the results suggest that the localization of CHC to the
spindle has a component that is independent of the interaction we
have characterized, most likely the N-terminus of clathrin/TACC
domain of TACC3, and other components of the complex such as
GTSE1 (Hubner et al, 2010; Hood et al, 2013).
Formation of a cryptic a-helix, stabilized by phosphorylation of
S558, contributes to CHC binding
We noticed that, in the structure of the pClACC fusion, residues
550–563 of phosphorylated TACC3 form an a-helix (a1P), whereas
the corresponding region of unphosphorylated TACC3 bound to
Aurora-A forms an a-helix at 546–555 (a1), but residues 556–563
adopt an extended conformation (Fig 7A and B). a1P is an extended
form of the shorter a-helix a1 that organizes the hydrophobic resi-
dues, such as Y560 and F563, that are critical for the interaction
with CHC (Fig 7C).
We used NMR spectroscopy to determine the extent to which
these a-helices are present in TACC3 in the absence of binding part-
ners in solution. Chemical shift index (CSI) plots were created for
phosphorylated and unphosphorylated TACC3CID following standard
methods (Fig 7D and E; Wishart & Sykes, 1994). In addition to
calculating a-proton chemical shifts we also measured secondary
chemical shifts for a-carbons. After the type of amino acid, the main
contribution to chemical shifts of a-carbons is the w angle and thus
the backbone conformation. Proximity of charges or aromatic side
chains which can strongly affect proton chemical shifts has virtually
no effect on the chemical shifts of a-carbons which makes them
very robust probes of backbone conformation. CSI analysis of
▸Figure 6. Mutations in the TACC3/CHC interface reduce spindle localization of the complex.A Cartoon representation of the TACC3/CHC interface (orange and grey, respectively). Key CHC residues are shown as spheres.
B FP binding curves of CHC 1–574 mutants with FAM-phospho-TACC3CID. Affinities are in parentheses. Data represents mean of three experiments  SD.
C Representative confocal images of HeLa cells at metaphase expressing the indicated GFP-TACC3 construct on a background of TACC3 depletion and stained for
tubulin and CHC. Below, scatter plot to show mitotic spindle enrichment of TACC3 constructs (red) and endogenous CHC (blue); GFP controls are pale red. ANOVA
with Tukey’s post hoc test, only comparison of TACC3 constructs with WT is shown. *P < 0.05, ***P < 0.001.
D Representative confocal images of HeLa cells at metaphase expressing the indicated GFP-CHC construct on a background of CHC depletion and stained for tubulin
and TACC3. Below, scatter plot to show mitotic spindle enrichment of CHC constructs (blue) and endogenous TACC3 (red); GFP controls are pale blue. ANOVA with
Tukey’s post hoc test, only comparison of CHC constructs with WT is shown. **P < 0.01, ***P < 0.001.
Data information: Each spot represents the average measurement per cell. Bars show mean values  standard deviation. Scale bar, 10 lm.
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synthetic TACC3CID peptides indicated a tendency towards helix
formation in the unphosphorylated peptide, but a much higher
propensity in the phosphorylated peptide, especially within residues
559–564 (Fig 7E). We concluded that phosphorylation of S558
increases the propensity for a-helix formation in TACC3, and we
examined the structure to identify the mechanism.
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Figure 7. Phosphorylation of S558 promotes formation of an a-helix that binds CHC.
A Structure of unphosphorylated TACC3N-ACID extracted from site 2 of the complex with Aurora-A. Disordered side chains are marked with asterisks.
B Two views of phosphorylated TACC3CID extracted from the complex with CHC. Polar interactions are marked with dashed lines.
C Superposition of the structures from panels (A) and (B) shows the transition in residues 558–563 from extended conformation to a-helix.
D Superposition of the 13C-HSQC spectra of unphosphorylated (red) and phosphorylated S558 (blue) TACC3 549–570 peptides. Shown is the region of the Ca-Ha
correlations from which the data for the secondary chemical shifts calculations were derived.
E Secondary chemical shifts for unphosphorylated (red) and phosphorylated S558 (blue) TACC3 549–570 peptides. Data for aH are shown on the top and aC on the
bottom.
F FP binding curves of CHC 1–574 with WT and mutant FAM-phospho-TACC3CID. Affinities are in parentheses. Data represent mean of three experiments  SD.
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S558 is positioned in-between basic residues, R555 and K562,
which are on the same face of the helix and are therefore positioned
to form salt bridges with the phosphorylated side chain that could
act as a “staple” to stabilize the a-helix (Fig 7B). In addition, the
side chain of K556 forms another “staple” through interaction with
Ser552. However, the positions of these basic side chains are not
clearly resolved in the electron density maps, which are based on
diffraction data of modest resolution and high B-factor
(Appendix Figs S2E and S3). We probed the contribution of these
interactions to the CHC/TACC3CID interaction using the FP assay
(Fig 7F). The R555A mutation alone or in combination with K556A
reduced the affinity by a factor 4–5, similar to that of the unphos-
phorylated TACC3CID peptide (216  11 lM; Fig EV5C), whereas
the effect of the K562A mutation was negligible (Fig 5G). R555 does
not interact directly with CHC, and so we conclude that it contri-
butes to CHC binding through an intramolecular “staple” interaction
that stabilizes the extended helix a1P. Taken together, these data
indicate that phosphorylation stabilizes a helical conformation of
TACC3, which places a series of critical hydrophobic side chains
into the correct positions to interact with the complementary
hydrophobic surface of CHC.
Structural studies revealed that the ACID region of TACC3 has
three separate motifs that mediate molecular recognition events at
each step of the pathway (Fig 8). The first motif docks TACC3 to the
N-lobe of Aurora-A. The second motif, which is the site of protein
phosphorylation, is recognized in its extended conformation by the
active site of Aurora-A and then undergoes a conformational transi-
tion to form an a-helix. The third motif is recognized by CHC, pref-
erentially in the context of an a-helix, formation of which depends
on the previous two steps.
Discussion
A late mitotic role for the Aurora-A/TACC3 interaction
Aurora-A contributes to the function of the spindle throughout mito-
sis, regulating the generation of a robust, bipolar spindle during
early mitosis, and contributing to spindle disassembly in late mitosis
(Lioutas & Vernos, 2013; Reboutier et al, 2013). These temporally
distinct functions were found initially by acutely inhibiting Aurora-
A using antibody injection of cells at defined time points, resulting
in delays and microtubule defects during anaphase (Marumoto et al,
2003). Conditional knockout of AURKA in chicken DT40 cells
showed that, surprisingly, Aurora-A is dispensable for bipolar
spindle assembly, although this process is much slower in its
absence, and that the major phenotype results from defects and
delays in anaphase (Hegarat et al, 2011). More recently, taking
advantage of chemical genetic approaches, TACC3 and p150glued
were identified as Aurora-A substrates that contribute to micro-
tubule stability and central spindle assembly (Lioutas & Vernos,
2013; Reboutier et al, 2013). Here, we show that abrogation of the
docking interaction between Aurora-A and TACC3 generates a delay
after metaphase. A role for Aurora-A and TACC3 in central spindle
assembly and elongation has been described previously (Marumoto
et al, 2003; Lioutas & Vernos, 2013). Although we detect some delay
in anaphase to telophase progression in F525A-HeLa cells, most of
this occurs between telophase and cytokinesis in both the TACC3
null and F525A-HeLa cells. The reduced spindle localization of the
F525A mutant in HeLa cells is similar to what we previously
observed with the F525A equivalent mutation in chicken DT40 cells,
but there is a critical difference in the mitotic timings between these
cellular systems. The F525A equivalent mutation in DT40 cells
shortened the duration of NEBD to anaphase onset by ~5 min,
whereas F525A-HeLa cells exhibited a delay of ~35 min compared
to single-cloned controls, suggesting increased reliance of spindle
assembly in HeLa cells on TACC3-containing inter-microtubule
bridges. Indeed, these bridges are likely to play a more central role
in stabilizing human K-fibres that contain 20–40 microtubules, than
DT40 K-fibres, which comprise only ~4 microtubules (Ribeiro et al,
2009; Nixon et al, 2015). The localization of TACC3 to spindle
microtubules depends on Aurora-A kinase activity, which is mainly
driven by its interaction with TPX2, and is antagonized by PP6
(Eyers et al, 2003; Tsai et al, 2003; Manfredi et al, 2007; Zeng et al,
2010). In turn, TACC3 localization is dependent on phosphorylation
(Giet et al, 2002; Kinoshita et al, 2005; Peset et al, 2005). Our
results therefore show that the docking interaction between Aurora-
A and TACC3 also makes a major contribution to TACC3 spindle
localization. This interaction increases the efficiency of TACC3
phosphorylation by both enhancing Aurora-A catalytic activity and
tethering the kinase close to the S558 phosphorylation site. These
effects can contribute throughout mitosis; however, the ability of
TACC3 to both dock to Aurora-A and activate the kinase locally
appears to be most critical in late mitosis when it is physically sepa-
rated from the pool of TPX2-activated Aurora-A. We have begun to
probe this model; however, it is challenging to study the dynamic
and localized activity of Aurora-A in cells because activation loop
phosphorylation on T288, which can be detected by antibody or
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biosensor, is not an absolute marker of activity and unphosphory-
lated kinase can also be highly active (Dodson & Bayliss, 2012;
Bertolin et al, 2016).
Structural insights into clathrin flexibility and interactions
The structure of CHC is best characterized as coat assemblies
formed by arrays of CHC-triskelia (Kirchhausen, 2000; Brodsky,
2012). The CHC triskelion is a three-legged structure, formed by
three heavy chains, each associated with a light chain. CHC
contains an N-terminal b-propeller domain and an extended
region containing helical repeats categorized into linker, ankle,
distal leg, knee, and proximal leg, while the C-terminus has a
trimerization domain (Appendix Fig S4A; Fotin et al, 2004). Cryo-
EM studies have described the structure of CHC to 7.9 A˚ (Fotin
et al, 2004); however, atomic resolution structures are known
only for the b-propeller domain and linker (aa1–494; ter Haar
et al, 1998) and a part of the proximal leg (aa1210–1516; Brodsky,
2012) and there is a near-atomic resolution crystal structure of the
trimerization domain (aa1521–1654; Ybe et al, 2013). Here, we
extend the knowledge of CHC structure at high resolution to resi-
dues 1–574. The conformation of the ankle region of CHC is more
compact in the ClACC structure compared to the previous struc-
ture of CHC 1–494, which could be a consequence of TACC3
binding between two helices of the repeat (Appendix Fig S2I and
J). It is worth noting that this binding site could be exploited by
other CHC-binding partners. Indeed, we noticed that the auxilin-
binding site within the CHC lattice lies in close proximity to the
TACC3-interacting region of the ankle domain (Appendix Fig
S4B). If auxilin and TACC3 do share a common binding site on
CHC, this could explain an earlier observation in which auxilin
depletion resulted in sequestration of TACC3 in CHC-coated vesi-
cles (Borner et al, 2012).
A site for substrate docking and allosteric regulation on the
N-lobe of Aurora-A
We have resolved why a region 30aa N-terminal to the phosphoryla-
tion site is critical for TACC3 binding to Aurora-A. The region of
TACC3 that is phosphorylated has low affinity for Aurora-A, and the
binding affinity of this substrate is primarily through a docking
motif that also stimulates kinase activity. Substrate docking interac-
tions that allosterically regulate kinase activity through conforma-
tional changes have been previously observed in MAP kinases and
AGC kinases (Goldsmith et al, 2007). Interestingly, three different
substrates of Aurora-A (TACC3, TPX2, and N-Myc) have three
distinct docking sites that can all be used to stimulate kinase activ-
ity. Other kinases engage the N-cap pocket as a site for regulation.
For example, the SH2 domain of the tyrosine kinase Abl acts as an
allosteric activator through interactions at the N-cap pocket, and
I164 of Abl fulfils a structurally equivalent role to that of
TACC3 L532 (Fig EV3D; Nagar et al, 2006; Filippakopoulos et al,
2008). The N-cap pocket is a binding site for small-molecule allos-
teric activators of AMPK (Xiao et al, 2013; Calabrese et al, 2014).
However, the closest analogy to the Aurora-A/TACC3 interaction is
CK2, which comprises a catalytic subunit (CK2a) bound to a dimer
of noncatalytic subunits (CK2b), which can be recapitulated using a
short, cyclic peptide (Pc) based on CK2b (Niefind et al, 2001; Raaf
et al, 2013). A crystal structure of CK2a/Pc shows a remarkable
similarity with the Aurora-A/TACC3 interface, with F190 of Pc/
CK2b taking the role of TACC3 L532 (Fig EV3E). AGC kinases have
a C-terminal region extension that wraps around the catalytic
domain, and inserts a hydrophobic residue into the N-cap pocket,
such as I335 of PKA (Knighton et al, 1991). However, the role of
these interactions in promoting kinase activity has been enigmatic.
Here, we propose that TACC3 activates Aurora-A through an inter-
action at the N-lobe pocket by destabilizing an inactive conforma-
tion of the kinase in which the side chain of Phe275 (from the
DFG-motif) blocks the C-helix in a distorted conformation. This
mechanism is similar in principle to the activation of tyrosine
kinases through conformational changes that facilitate the flip of the
DFG-motif (Levinson et al, 2006), and we speculate that a similar
mechanism may contribute to the activation of other kinases
through interactions at their N-lobe pockets.
A flexible, non-canonical mechanism of phospho-recognition
We have resolved how phosphorylated TACC3 is handed over from
Aurora-A to CHC (Fig 8). Aurora-A phosphorylates S558 in the
context of an extended peptide conformation, which is necessary for
it to be accommodated in the cleft that recognizes substrates. Phos-
phorylation at S558 triggers a localized disorder to order transition,
stabilizing and extending a nascent helix. The structural basis of
TACC3 binding to CHC is unusual in that CHC recognizes the struc-
tural consequence of phosphorylation. This explains how CHC
recognizes phosphorylated TACC3 even though it does not have a
canonical pSer binding domain. We propose that the a1P-helix of
TACC3 is stabilized through formation of an intramolecular salt
bridge with R555 that acts as a staple to hold this region of TACC3
in a helical conformation. Salt bridges formed between glutamate
and lysine/arginine residues stabilize long helices in the context of
naturally occurring single alpha-helix (SAH) domains, such as those
found in myosins 6 and 10, or synthetic model SAH domains
(Wolny et al, 2017). These give rise to constitutively a-helical
proteins, however, in TACC3, the formation of the salt bridge is regu-
lated by Aurora-A kinase. The presence of an arginine three residues
N-terminal to the phosphorylation site (P-3) is a conserved feature of
the substrates of basophilic kinases such as Aurora-A or PKA and is
recognized by an acidic pocket in the C-lobe of these kinases
(Knighton et al, 1991). Therefore, we expect that the stabilization
of helices by phosphorylation could be a recurring mechanism for
the regulation of protein–protein interactions by basophilic kinases.
Materials and Methods
DNA manipulation
Expression vectors, pET30TEV Aurora-A 122–403 C290A, C393A,
pET30TEV Aurora-A 122–403, pET30TEV Aurora-A 1–403 D274N,
pETM6T1 TACC3 519–563, and pET44c TACC3 519–563-H6c, were
produced in earlier work (Bayliss et al, 2003; Burgess et al, 2015;
Rowan et al, 2013).
The expression construct, pETM6T1 TACC3 519–540, was
produced by the introduction of a stop codon into the vector,
pETM6T1 TACC3 519–563 at residue 541 by site-directed
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mutagenesis using PfuTurbo polymerase (Agilent). Point mutations
in pET44c TACC3 519–563-H6c and pET30TEV Aurora-A 122–403
C290A, C393A were produced in a similar manner.
For co-expression with pETM6T1 TACC3 519–563, the coding
sequence of Aurora-A 122–403 D274N, C290A, C393A was
subcloned into pCDF.
Overlapping extension PCR was performed to make the chimeric
construct CHC 1–574-TGS4-TACC3 549–570
S558TAG-TEV site 6xHis-
Tag (ClACCp). The construct was subcloned in pNHD (Rogerson
et al, 2015) using the restriction sites BsrG1 and Xho1 to produce
the vector, pNH-ClACCp. The amber codon at S558 was introduced
into TACC3 by site-directed mutagenesis for incorporation of
synthetic phosphoserine by orthogonal aminoacyl-tRNA synthetase/
tRNACUA pairs via the genetic code expansion method (Rogerson
et al, 2015).
For binding studies, CHC constructs were cloned in a modified
pGEX vector containing a TEV-cleavable GST tag and point muta-
tions introduced by site-directed mutagenesis.
For expression of GFP-CHC or GFP-TACC3 mutants in cells
depleted of endogenous proteins, the pBrain system was used (Hood
et al, 2013). New mutants were generated by site-directed mutagen-
esis.
Protein expression and purification
Aurora-A, TACC3, and TPX2 constructs were expressed and purified
as described in previous work (Burgess et al, 2015).
Double-labelled 13C15N TACC3 519–540 was expressed and puri-
fied as described for 13C15N-TACC3 519–563 (Burgess et al, 2015).
The protein was concentrated using Spectra gel as per the manufac-
turer’s instructions (Spectrum).
To generate diffraction-quality complexes, we used a construct of
Aurora-A (Aurora-AM3KD) that was mutated in three places: D274N
prevents coordination to magnesium, inactivates the kinase, and
thus prevents heterogeneous phosphorylation of the proteins, and
C290A, C393A stabilizes Aurora-A and improves the diffraction limit
of Aurora-A crystals (Burgess & Bayliss, 2015). To produce the
Aurora-A/TACC3 complex for crystallization trials, the expression
vectors, pCDF Aurora-A 122–403 D274N, C290A, C393A, and
pETM6T1 TACC3 519–563 were co-transformed into Escherichia coli
BL21(DE3)RIL cells and recombinant protein expression and purifi-
cation carried out as described previously for TACC3 constructs
(Burgess et al, 2015). As a final purification step, the complex was
subject to size-exclusion chromatography using a Superdex 200 16/
600 column (GE Healthcare) equilibrated in 20 mM Tris pH 7.0,
200 mM NaCl, 5 mM b-mercaptoethanol, 5 mM MgCl2, and 10%
glycerol.
For expression of ClACCp containing unnatural phosphoserine
at S558 site on TACC3 549–570, pNH-ClACCp was transformed in
E. coli BL21 DserB(DE3) cells containing pKW2-EF-Sep (Rogerson
et al, 2015). Colonies were grown overnight in terrific broth (TB)
containing 30 lg/ml chloramphenicol and 25 lg/ml tetracycline.
The overnight cultures were used to inoculate 12 × 1 l TB
containing the appropriate antibiotics and 2 mM phosphoserine.
The cultures were subsequently incubated at 37°C at 200 rpm. At
OD600 ~0.7–0.8, 200 lM IPTG and 2 mM phosphoserine were
added and the cultures incubated for a further 16 h at 18°C and
200 rpm. The cells were harvested by centrifugation and
resuspended in lysis buffer (50 mM Tris pH 9.0, 200 mM NaCl,
1 mM b-mercaptoethanol) containing 2.5 mM PMSF and lysed by
sonication. The cell lysate was clarified by centrifugation and
subsequently purified using a HisTrap affinity column (GE Health-
care) equilibrated in lysis buffer and eluted with an imidazole
gradient (20–400 mM). The protein was dialysed against 20 mM
Tris pH 9.0, 200 mM NaCl, 1 mM EDTA, 5 mM DTT at 4°C in
the presence of His-tagged TEV protease to remove the C-terminal
His-tag. The cleaved His-tag and His-tagged TEV protease were
removed by pass-back over HIS-Select Nickel Affinity Gel (Sigma).
The protein was further purified by anion exchange chromatogra-
phy using 5 ml HiTrap Q HP column (GE Healthcare) equilibrated
in 20 mM Tris pH 9.0, 5 mM DTT and eluted with increasing salt
concentration (1 M). The complex was polished by size-exclusion
chromatography using a Superdex-200 16/600 column (GE Health-
care) equilibrated in 20 mM HEPES–NaOH pH 7.5, 150 mM NaCl,
5 mM DTT.
GST-tagged CHC proteins were purified using standard proce-
dures and the GST tag cleaved on-column using TEV protease. The
flow-through after TEV cleavage was further purified using anion
exchange chromatography and size-exclusion chromatography as
described for ClACCp constructs.
Protein crystallization
The Aurora-A 122–403 D274N, C290A, C393A/TACC3 519–563
complex was concentrated to 16.5 mg/ml; 5 mM ADP/MgCl2 was
added to the complex and incubated on ice for 1 h. The complex
was screened against a range of commercial crystallization matrices.
Drops were laid down at a 1:1 ratio of complex:precipitant in MRC
sitting drop plates using a Mosquito LCP crystallization robot
(ttplabtech) and incubated at 18°C. Cubic crystals were produced
using 0.1 M Bis–Tris pH 5.5, 2 M ammonium sulphate as the precip-
itant after 2–3 days. Crystals were flash-frozen in liquid nitrogen
with the addition of 30% ethylene glycol to the mother liquor to act
as a cryoprotectant.
Diffraction data were collected from a single crystal at Diamond
Light Source (Oxford, UK) on beamline I04-1. Autoprocessed data
from xia2 “3-daii” pipeline at Diamond Light Source were used for
structure determination (Winter, 2010). Molecular replacement was
performed in PHASER (McCoy et al, 2007) using the Aurora-A 122–
403 C290A, C393A structure as a model (PDB 4CEG; Burgess &
Bayliss, 2015). Clear difference density was observed for TACC3
519–563 and this was modelled in using Coot (Emsley & Cowtan,
2004). Subsequent rounds of iterative refinement were performed
using Phenix (Adams et al, 2002) and Coot. MolProbity was used to
determine structure quality (Chen et al, 2010).
ClACCp (10 mg/ml) was crystallized using the hanging drop
vapour diffusion method. Diffraction-quality crystals were obtained
by mixing 1.5 ll protein with 1.5 ll reservoir solution containing
0.1 M Tris pH 8.0, 0.12 M NaCl, 8% w/v polyethylene glycol 6000,
25% ethylene glycol. Crystals were flash-frozen in liquid nitrogen
upon harvesting without additional cryoprotectant.
Diffraction data were collected at Diamond Light Source (Oxford,
UK) at beamline I03. Autoprocessed data were used for molecular
replacement using PHASER (McCoy et al, 2007) with CHC 1–494
(PDB 1BPO; ter Haar et al, 1998) as the search model. Four mole-
cules were located in asymmetric unit. Subsequent iterative
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refinement cycles were performed using Buster (Blanc et al, 2004),
Phenix (Adams et al, 2002) and Coot (Emsley & Cowtan, 2004).
MolProbity was used to assess geometry (Chen et al, 2010).
Biochemical assays
Radioactive 32P-ATP kinase assays were performed as described
previously (Burgess et al, 2015). In brief, 0.625 lM Aurora-AM3KD
WT or selected mutant was incubated with 0.25 mg/ml MBP
alone and in the presence of 5 lM TACC3N-ACID WT or mutant
for 10 min. Reactions were terminated by the addition of 2%
(v/v) orthophosphoric acid. Samples were spotted onto P81
Whatman paper, washed extensively with 0.2% (v/v) orthophos-
phoric acid and incorporation of radioisotope measured by scintil-
lation counting.
Autophosphorylation assays were performed as for radioactive
32P-ATP reactions using Aurora-A 122–403 co-expressed with
lambda phosphatase for 1 h at room temperature with His-Aurora-A
D274N as a substrate in replace of MBP. Reactions were resolved by
SDS–PAGE and subject to Western blotting using an a-phospho-
T288 Aurora-A antibody (CST 2914, 1:2,000) as per the manufac-
turer’s recommendation.
Aurora-A/TACC3 fluorescence polarization assays were
performed as stated (Richards et al, 2016) using FAM-TACC3
peptides (PPR, Cambridge; Almac, Craigavon). Binding assays were
performed in triplicate. FP signal was fit to a one-site total binding
model in Prism 6 (GraphPad). Results are reported as Kd  SE.
For CHC-TACC3 FP assays, CHC proteins were serially diluted in
FP buffer (20 mM HEPES–NaOH pH 7.5, 200 mM NaCl, 5 mM
DTT). FAM-labelled TACC3 peptide was added to a final concentra-
tion of 50 nM and incubated for 30 min at room temperature to
allow binding to reach equilibrium. Fluorescence polarization
measurements were made using a Victor X5 plate reader (Perkin
Elmer) at 25°C with excitation at 490 nm and emission at 535 nm.
Data analysis was performed as described above.
NMR spectroscopy
Side chain assignments of TACC3 519–563 & 519–540 were
obtained from 15N/13C-labelled samples expressed as described
before (Burgess et al, 2015) in 20 mM KPO4 pH 7.0, 50 mM
NaCl, 1 mM DTT, 0.02% (w/v) sodium azide at a protein
concentration of 300 lM. 3D H(CCCO)NH, (H)C(CCO)NH, 13C
HCCH-TOCSY, 13C NOESY-HSQC and 13C HSQC spectra were
recorded for these peptides alone and in complex with Aurora-A
122–403 D274N on a Bruker Avance spectrometer operating at a
1H frequency of 700 MHz and a temperature of 298K. Spectra
were recorded and processed using Bruker TopSpinTM 3.2 software
(Bruker Biospin AG: Fa¨llanden, Switzerland) and analysed using
CCPN analysis.
For analysis of TACC3 549–570 helicity, synthetic peptides were
weighed in to give a sample concentration of 2 mM in 20 mM Tris
pH 7.2 and 50 mM NaCl. Spectra were recorded at a temperature
of 290 K on a Bruker Avance-Neo 600 MHz spectrometer equipped
with a prodigy cryoprobe. Peptides were assigned using 2D
NOESY, TOCSY and 13C HSQC spectra recorded with watergate
and gradient coherence selection, respectively. Assignment and
chemical shift analysis was performed in CCPN analysis version
2.4. This software does not have standard random coil chemical
shifts values for phospho-serine so it was not possible to calculate
secondary chemical shift values for pS558 in the phosphorylated
peptide.
Generation of TACC3 variants in HeLa cells by genome
engineering
TACC-domain deletion and TACC3-F525A variants in HeLa cells
were prepared by CRISPR-Cas9 method (Ran et al, 2013). See target-
ing strategy in Appendix Fig S1. Briefly, three guide RNAs with
targeted cleavage sites near codon for F525 of human TACC3
(Appendix Fig S1) were identified. To introduce the F525A point
mutation, a single-stranded oligodeoxynucleotide (ssODN) was used
as a template.
The guide RNAs were phosphorylated and cloned into BbsI-
digested pX459 vector (Addgene; plasmid #48139). The guide RNA
pairs (Sigma) were as follows:
gRNA1 (CACCGGCTCTCCTCTTTCAGCTCCA and AAACTGGAGCTG
AAAGAGGAGAGCC),
gRNA2 (CACCGCAGGCAACGTACCCTCAGCG and AAACCGCTGA
GGGTACGTTGCCTGC) and
gRNA3 (CACCGGCCAGGCAACGTACCCTCAG and AAACCTGAGGG
TACGTTGCCTGGCC).
The sequence of the ssODN is as follows: GCCTTGAACTCTGCC
AGCACCTCGCTTCCCACAAGCTGTCCAGGCAGTGAGCCAGTGCCCA
CCCATCAGCAGGGGCAGCCTGCATTGGAGCTGAAAGAGGAGAGCG
CTAGAGATCCAGCTGAGGgtacgttgcctggcacagacgtcacacacagtctgcccgg
aggggatcccgtgagcacttgggcagctcgagacac with exon in upper and intron
in lower case; AfeI restriction site in bold, which also includes the
F525A mutation; the PAM sites for all three gRNAs were removed by
introducing silent mutations (Appendix Fig S1).
Transfections were carried out using Lipofectamine 3000 (Invit-
rogen) and following manufacturer’s guidelines. The day after trans-
fection, cells were subjected to antibiotic selection using 0.5 lg/ml
puromycin (Sigma) for 4 days. Surviving cells were serially diluted
to one cell per well in 96-well plates. Single clones were expanded
and screened by PCR amplification (Phusion, NEB) of the targeted
genomic region (FP1-intron3: TGCCCCAGCCTCCACATTTGAAG and
RP1-intron5: GGTTCAGGCTTCACATTTCATTATCAAG) (Appendix
Fig S1) followed by restriction digestion with AfeI.
For promising clones, total RNA was isolated (QIAGEN RNeasy
kit) with SuperScript III reverse transcriptase (Invitrogen). Using
cDNA as template, the targeted region of TACC3 was PCR-amplified
(Phusion, NEB) (FP2-exon3: GAGTGACACCCGCCTCTGAGACCC
TAG and RP2-exon8: CGCGGACGTCCTGAGGGAGTCTC). The PCR
product was cloned into pJET1,2/Blunt (CloneJET; ThermoFisher
scientific), and a minimum of 15 bacterial colonies was sequenced
(Appendix Fig S1).
Western blot analysis was carried out using rabbit polyclonal
antibody raised against aa 73–265 of human TACC3 (Gergely et al,
2000). TACC-domain deletion mutants were identified as a by-
product of the CRISPR knock-in genome engineering.
Cell culture and synchronization
HeLa WT, DTACC and F525A cells were maintained in Dulbecco’s
modified Eagle medium (DMEM) with GlutaMAX (Invitrogen)
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supplemented with 10% heat-inactivated FBS, 100 U/ml penicillin,
and 100 lg/ml streptomycin at 37°C in a 5% CO2 atmosphere. Cell
synchronization was achieved by a double-thymidine block. Cells at
30% confluency were treated with 2 mM thymidine in DMEM
supplemented with 10% FBS for 18 h, released in growth media for
9 h, before addition of 2 mM thymidine for a further 17 h. Synchro-
nization was confirmed by flow cytometry.
For RNAi and re-expression of GFP-tagged proteins in HeLa cells,
siRNA and pBrain plasmids were used. Briefly, for TACC3, cells
were transfected with siRNA on day 0, transfected 10 h later with
pBrain plasmid and analysed on day 2. For CHC, cells were trans-
fected with siRNA on day 0, transfected with pBrain plasmids on
day 2 and fixed on day 4.
Proximity ligation assay and microscopy
For PLA assays, cells grown on acid-etched glass coverslips were
fixed with ice-cold methanol and incubated at 20°C for at least
15 min. Cells were rehydrated with phosphate-buffered saline
(PBS) and blocked with 1% bovine serum albumin (BSA) in PBS
for 30 min before incubation at room temperature for 1 h with
the appropriate antibody diluted in 3% BSA in PBS. Primary anti-
bodies used were mouse Aurora-A (Sigma, 1:500), rabbit TACC3
(Abcam, 1:200), and rabbit TPX2 (Novus biologicals, 1:500). A
Duolink kit (Olink Bioscience, Uppsala, Sweden) was used
according to the manufacturer’s guidelines. Briefly, coverslips
were incubated with secondary antibodies conjugated with
oligonucleotides, PLA probe anti-mouse MINUS and PLA probe
anti-rabbit PLUS, diluted in 3% BSA in PBS, for 1 h at 37°C
inside a humidified chamber. After washes, cells were incubated
at 37°C for 30 min with ligation mixture containing ligase.
Following this, an amplification solution containing polymerase
was incubated on the coverslips for 100 min at 37°C. Imaging
was performed on a Zeiss LSM880 upright confocal microscope
using a 40× oil objective (numerical aperture, 1.4). Z-stacks
comprising 12–15 0.45 lm sections were acquired using Zen 2.1
software (Zeiss). Quantification of PLA dots was done using
Imaris 8.3.0 software (Bitplane).
Primary antibodies used to analyse HeLa cell lines were
TACC3 (against human TACC3 residues 73–265, 1:1,000, rabbit
(Gergely et al, 2000); a-tubulin (Sigma-Aldrich, Dm1a, T9026,
1:1,000, mouse); Cas9 (Cell Signaling, 14697, 1:1,000, mouse).
For a-tubulin staining, cells were fixed with 4% formaldehyde
(Fisher Scientific) in PBS containing 0.01% Tween 20 (Promega)
for 12 min at 37°C followed by permeabilization with
PBS + 0.5% Triton X-100 (Acros Organics) at 37°C for 10 min.
PBS + 5% BSA (Sigma-Aldrich) was used for blocking followed
by incubation in primary antibodies for 1 h at 37°C for each
step. After three washes of 5 min each in PBS + 0.1% Tween 20,
cells were incubated with 1:1,000 diluted goat anti-rabbit Alexa
Fluor 488 and goat anti-mouse Alexa Fluor 555 (Life Technolo-
gies) for 1 h at 37°C. After washing as described above, DNA
was stained with 1 lg/ml Hoechst 33258 (Sigma-Aldrich) in PBS
for 10 min followed by mounting in ProLong Diamond anti-fade
(Invitrogen).
Fixed cells that were mounted in anti-fade medium were imaged
on a scanning confocal microscope (Leica SP5) with 60×, 1.4 NA
objective (Leica). Images presented are 3D projections of z-sections
taken every 0.5 lm across the cell. Images of any individual figure
were acquired using the same settings and were imported into
Volocity 6.3 (Perkin Elmer) or Photoshop CS6 (Adobe). Live cell
imaging of HeLa WT TACC3 and variants was carried out on Zeiss
Widefield Cell Observer Live Cell imaging system equipped with
heating/CO2 units using Plan-Apochromat 40×/0.95 NA Korr Ph3
M27 dry objective. Cells were seeded at 40,000 cells/well in to
l-slide 8-well dish (Ibidi, 80826); 30 min before imaging, the cells
were washed once with FluoroBrite DMEM (A18967, Life Technolo-
gies) supplemented with 10% heat-inactivated FBS (Life Technolo-
gies) and 2 mM L-glutamine (Life Technologies) followed by the
addition of 300 ll/well of the same medium containing 0.3 lM SiR-
DNA (SC007, SPIROCHROME). Images were acquired in brightfield
and Cy5 settings, every 5 min for 24 h with a step size of
3 × 1.5 lm. The cell cycle timings were analysed using ZEN 2 lite
software. Statistical analyses and preparation of graphs were
performed using Prism7 (GraphPad Software, Inc.). Numbers of
experimental repeats (n values) are reported for each dataset in fig-
ures and figure legends.
For immunofluorescence studies on the CHC/TACC3 interface
mutants, cells were fixed with PTEMF (50 mM PIPES, pH 7.2,
10 mM EGTA, 1 mM MgCl2, 0.2% Triton X-100, and 4%
paraformaldehyde) for 15 min at RT, and then permeabilized (PBS
with 0.1% Triton X-100) for 10 min. Cells were blocked (PBS with
3% BSA, 5% goat serum) for 30 min, and then incubated for 1 h
with the specified primary antibodies: mouse anti-CHC (X22, Affin-
ity BioReagents, 1:1,000), rabbit anti-alpha tubulin (Thermo, PA5-
19489, 1:1,000), mouse anti-TACC3 (AbCam, ab56595, 1:1,000).
Secondary antibodies labelled with Alexa Fluor 568 or Alexa Fluor
647 from Life Technologies (diluted 1:500) were used along with
DAPI. Images were taken using a Nikon Ti epifluorescence micro-
scope with 100× objective (1.4 NA) and a Coolsnap Myo camera
(Photometrics; Tucson, AZ). Equal exposure settings and scaling
were used between conditions.
For spindle enrichment analysis, mean pixel density in two
10 × 10 pixel ROI was measured either over the spindle (away
from poles), in the cytoplasm or in a non-cell region of back-
ground, using ImageJ. Background was subtracted from the
spindle and cytoplasm measurements, and spindle fluorescence
was then divided by cytoplasm fluorescence. Sample sizes 48–53
cells (TACC3) and 36–51 cells (CHC) over two experiments were
analysed per condition. Ratios were analysed from cells with
comparable fluorescence. Differences in spindle recruitment were
evident at all expression levels. IgorPro was used to find and plot
the ratio of spindles to cytoplasmic fluorescence intensity per cell.
Images were cropped in ImageJ, and figures were assembled in
Adobe Illustrator. Some images were contrast adjusted for presen-
tation.
Measurement of TACC3 volume at spindle pole regions
Quantification of the volume of TACC3 in spindle pole areas
was done using Imaris 8.3.0 software (Bitplane). Briefly, maxi-
mum intensity projections of telophase cells were generated from
z-stacks imaged using identical confocal settings and opened in
Imaris. Surfaces were generated for voxels with intensities > 50,
and volumes at spindle poles were selected and recorded indi-
vidually.
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Data availability
The structure coordinates from this publication have been deposited
to the RCSB PDB database (www.rcsb.org) and assigned the identi-
fiers, 5ODS and 5ODT.
Expanded View for this article is available online.
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